Centene Corporation (NYSE:CNC) Q4 2021 Earnings Conference Call February 9, 2022 11:00 AM ET Company Participants Jennifer Gilligan - Senior Vice President, Investor Relations Michael Neidorff - Chairman & CEO Sarah London - Vice Chairman Brent Layton - President & COO Andrew Asher - Executive VP & CFO Jonathan Dinesman - EVP of Government Relations Conference Call Participants Josh Raskin - Nephron Research Stephen Baxter - Wells Fargo Kevin Fischbeck - Bank of America A.J. Rice - Crédit Suisse Scott Fidel ...

Centene Corporation (NYSE:CNC) Q3 2021 Earnings Conference Call October 26, 2021 8:30 AM ET Company Participants Jen Gilligan - Senior Vice President, Finance and Investor Relations Michael Neidorff - Chairman and Chief Executive Officer Sarah London - Vice Chairman Drew Asher - Executive Vice President and Chief Financial Officer Kevin Counihan - Senior Vice President, Products Conference Call Participants Josh Raskin - Nephron Research Matt Borsch - BMO Capital Markets A.J. Rice - Credit Suisse Kevin Fisc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ___________________________________________ FORM 10-Q ____________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ____________________________________________ | --- | --- | |---- ...

Centene Corporation (NYSE:CNC) Q2 2021 Earnings Conference Call July 27, 2021 8:30 AM ET Company Participants Jennifer Gilligan - Investor Relations Michael Neidorff - Chairman, President and Chief Executive Officer Drew Asher - Executive Vice President and Chief Financial Officer Brent Layton - Executive Vice President and President, U.S. Health Plans, Products and International Kevin Counihan - Senior Vice President, Products Sarah London - President, Healthcare Enterprises and Executive Vice President, A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ___________________________________________ FORM 10-Q ____________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ____________________________________________ | --- | --- | |--------- ...

Call Start: 08:30 January 1, 0000 9:22 AM ET Centene Corporation (NYSE:CNC) Q1 2021 Earnings Conference Call April 27, 2021 08:30 ET Company Participants Jennifer Gilligan - Senior Vice President, Finance & Investor Relations Michael Neidorff - Chairman, President & Chief Executive Officer Jeff Schwaneke - Executive Vice President & Chief Financial Officer Sarah London - Senior Vice President, Technology Innovation & Modernization Brent Layton - Executive Vice President Conference Call Participants Josh Ras ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ___________________________________________ FORM 10-Q ____________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |----------------------------------------------------- ...

CF 10 ion Oppenheimer Healthcare Conference March 16, 2021 Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this presentation are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative th ...

Accelerating Medicines March 2021 Disclaimer . The following presentation has been prepared by Certara, Inc. ("we", "us", or "the Company") solely for informational purposes and should not be construed to be, directly or indirectly, in whole or in part, an offer to buy or sell and/or an invitation and/or a recommendation and/or a solicitation of an offer to buy or sell any security or instrument or to participate in any investment or trading strategy, nor shall any part of it form the basis of, or be relied ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 Centene Corporation (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of ...